FDA Person
Office of the CommissionerAndrea A. Branche
View detailed information about Andrea A. Branche, including compliance records, violations, and related data.
Person Profile
FDA investigator, Office of the Commissioner. Took part in 84 inspections of 84 companies, 2016–2025.
Inspections (84)
| Date | Company | Classification | Project area | Inspection |
|---|---|---|---|---|
| March 21, 2025 | Hilda A. Mujuru | VAI | Bioresearch Monitoring | #1265731 |
| March 14, 2025 | Renate Strehlau, PhD | Not classified | #1265132 | |
| March 7, 2025 | Zoe Taryn Franckling Smith | Not classified | #1264727 | |
| February 20, 2025 | LivaNova USA, Inc. | Not classified | #1261017 | |
| January 31, 2025 | Alan Reichman, M.D. | Not classified | #1261978 | |
| December 5, 2024 | Dr. Jorge Antonio Piedrahita Olier, MD | NAI | Bioresearch Monitoring | #1256969 |
| November 27, 2024 | Steve E. Canfield, M.D. | VAI | Product Evaluation: Medical Devices | #1255226 |
| November 27, 2024 | Nfi | VAI | Bioresearch Monitoring | #1255226 |
| November 22, 2024 | Nanospectra Bioscience Inc | VAI | Product Evaluation: Medical Devices | #1255016 |
| October 18, 2024 | David M. Brown, MD/PI | NAI | Bioresearch Monitoring | #1252969 |
| September 27, 2024 | Anton Jorgensen, M.D. | Not classified | #1252417 | |
| August 15, 2024 | Glaukos Corporation | NAI | Bioresearch Monitoring | #1251714 |
| August 9, 2024 | Pharmaron (San Diego) Lab Services, LLC | Not classified | #1249074 | |
| July 16, 2024 | Peet John J MD | VAI | Human Cellular, Tissue, and Gene Therapies | #1244005 |
| May 24, 2024 | Phoebe Ho | NAI | Bioresearch Monitoring | #1243189 |
| May 8, 2024 | Rukan Daccak, M.D. | NAI | Bioresearch Monitoring | #1241466 |
| April 19, 2024 | Robert S. Mannel, M.D. | NAI | Bioresearch Monitoring | #1237406 |
| March 26, 2024 | Yasir Y. Elamin, M.D. | VAI | Bioresearch Monitoring | #1234195 |
| March 20, 2024 | Betul Oran, M.D. | VAI | Bioresearch Monitoring | #1233487 |
| February 23, 2024 | Jeff S. Bullock, M.D. | NAI | Bioresearch Monitoring | #1232430 |
Documents (37)
- 483 · BRI-IRB · February 7, 2013
- 483 · Eagle Analytical Services, Inc. · June 17, 2013
- 483 · BRI Institutional Review Board, Inc. · October 28, 2010
- 483 RESPONSE · Eagle Analytical Services, Inc. · June 17, 2013
- EIR · Oscar "Howard" Frazier · June 18, 2009
- EIR · Richard De La Garza, II, Ph.D · January 23, 2012
- EIR · Genentech, Inc. · October 7, 2022
- EIR · Union Carbide Corporation a subsidiary of The Dow Chemical Company · February 16, 2011
- 483 · GPC Medical Ltd. · June 19, 2017
- 483 · Naoto Ueno, M.D. · July 6, 2022
- 483 · Milton Hom, OD · September 3, 2021
- EIR · Immunity Bio, Inc · May 20, 2021
- 483 · Trinity Hospital IRB # 1 · October 11, 2019
- 483 · Steve E. Canfield, M.D. · November 27, 2024
- 483 · Nanospectra Bioscience Inc · November 22, 2024
- 483 · Eric Jonasch, M.D. · March 5, 2021
- 483 · Hans C. Lee, M.D. · January 10, 2020
- EIR · Diane Highum, M.D. · June 27, 2019
- EIR · Myron Reiff, M.D. · June 27, 2019
- 483 · DR. NELSON E. UZQUIANO · September 11, 2020
- 483 · Peet John J MD · July 16, 2024
- 483 · University of Texas Medical Branch · September 15, 2023
- 483 · Joseph C Gathe, Jr, MD, CI · March 10, 2023
- 483 · Myron Reiff, M.D. · June 27, 2019
- 483 · GLPGCP Development (Asia) Pte. Ltd. · June 22, 2017
- 483 · Northern Biomedical Research, Inc. · November 13, 2021
- 483 · Maggie Jeffries MD · August 5, 2021
- 483 · Harold S. Minkowitz, M.D. · April 30, 2018
- 483 · Diane Highum, M.D. · June 27, 2019
- EIR · Damien Sanderlin, MD · July 18, 2012
- EIR · Dexcom, Inc. · February 16, 2018
- 483 · GPC Medical Ltd. · June 22, 2017
- 483 · Luis Zepeda, M.D. · February 15, 2022
- 483 · Mobeen Mazhar, M.D. · April 28, 2022
- 483 · Edward Fox, M.D. · March 24, 2023
- 483 · Sabeen Najam, MD · January 20, 2021
- 483 · Fayz A. Hudefi, M.D. · April 21, 2023
Frequently inspected with (10)
Related Office
Person Information
Name
Andrea A. Branche
Title
CSO
Role
Regulatory Personnel
ID: 9ffe9b53-7963-49a6-be4e-25e644f1759f
Get More Insights
Access our comprehensive quality intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.
1.5M+ regulatory data points
Real-time compliance monitoring
Interactive analytics dashboard
Looking for more people? Our platform provides access to thousands of FDA people with advanced search and filtering capabilities.
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust KeyPedia for their regulatory compliance needs.